Comparison of Methods for Polycythemia Rubra Vera-1 mRNA Quantification in Whole-Blood Leukocytes and Purified Granulocytes

Lars Palmqvist(Sahlgrenska University Hospital), Anne Ricksten(Sahlgrenska University Hospital), Peter Johansson(Linköping University), Björn Andréasson(NU Hospital Group), Jack Kutti(Sahlgrenska University Hospital), Philipp S. Goerttler(University Hospital Ulm), Soodabeh Safai‐Kutti(Sahlgrenska University Hospital), Carina Wasslavik(Sahlgrenska University Hospital), Heike L. Pahl(University Medical Center Freiburg)

Clinical Chemistry

February 23, 2004

10.1373/clinchem.2003.028530

Cited by 4

Related Papers

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

|Journal of Clinical Oncology|2012|461

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients

|Blood|2011|340

Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms

|Journal of Clinical Oncology|2011|244

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

|The Lancet|2023|194

MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis

|Blood|2014|153